Effects of octreotide on cardiovascular hormones and haemodynamics in conscious dogs

Journal of Endocrinological Investigation

Volumn 19, Issue 2, 1996, Pages 106-113

  Donckier, J ^a   Stoleru, L ^b   Selvais, Ph ^b   Galanti, L ^a   Van Mechelen, H ^b   Ketelslegers, J M ^b   Charlier, A A ^b  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Atrial natriuretic factor; Atrial stretch; Octreotide

Indexed keywords

ADRENALIN; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CYCLIC AMP; ENDOTHELIN 1; GLUCOSE; OCTREOTIDE; SOMATOSTATIN RECEPTOR; VASOACTIVE AGENT;

ADRENALIN BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOG; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART RIGHT ATRIUM PRESSURE; HEMODYNAMICS; HORMONE RELEASE; HYPERVOLEMIA; NONHUMAN; PRESSOR RESPONSE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029871786     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349845     Document Type: Article

References (28)

1. Grosman I., Simon D. Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide. Am. J. Gastroenterol. 85: 1061, 1990.
2. Reichlin S. Neuroendocrinology. In: Wilson J.D., Foster D.W. (Eds.), Williams Textbook of Endocrinology. W.B. Saunders, Philadelphia, 1992, p. 135.
3. Patel Y.C. General aspects of the biology and function of so-matostatin. In: Weil C., Muller E.E., Thorner M.O., (Eds.), Somatostatin. Springer-Verlag, Berlin Heidelberg, 1992, p. 1.
4. Hou Z.Y., Lin C.I., Chiu T.H., Chiang B.N., Cheng K.K., Ho H.T. Somatostatin effects in isolated human atrial fibres. J. Mol. Cell. Cardiol. 19: 177, 1987.
5. Lin C.I., Ckeng K.K., Ho L.T. Electropharmacological effects of somatostatin in human atrial fibers. Int. J. Cardiol. 37:313, 1991.
6. Greco A.V., Ghirlanda G., Barone C., Bertoli A., Caputo S., Uccioli L., Manna R. Somatostatin in paroxysmal supraventricular and junctional tachycardia. Br. Med. J. 288: 28, 1984.
7. Anderson U.V., Donckier J., Mc Kenna W.J., Bloom S.R. The plasma release of atrial natriuretic peptide in man. Clin. Sci. 77: 151, 1986.
8. Edwards B., Zimmerman R., Schwab T., Heublein D., Burnett J. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ. Res. 62: 191, 1988.
9. Donckier J., Hanet C., Galanti L., Stoleru L., Van Mechelen H., Robert A., Ketelslegers J.M., Pouleur H. Low-dose endothelin-1 potentiates volume-induced secretion of atrial natriuretic factor. Am. J. Physiol. 263: H939-5, 1992.
10. Ferri C., De Mattia G., Bellini C., Laurenti O., Bravi C., Baldoncini R., Bonavita M.S., Santucci A., Balsano F. Octreotide, a somatostatin analog, reduces insulin secretion and increases renal Na+ excretion in lean essential hypertensive patients. Am. J. Hypertens. 6: 276, 1993.
11. Sicuteri F., Panconesi A., Del Bianco P., Franchi G., Anselmi B. Venoplastic activity of somatostatin in vivo in man: naloxone reversible tachyphylaxis. Int. J. Clin. Pharmacol. Res. 4: 253, 1984.
12. Hoeldtke R.D., Davis K.M., Joseph J., Gonzales R., Panidis J.P., Friedman A.C. Hemodynamic effects of octreotide in patients with autonomic neuropathy. Circulation 84: 168, 1991.
13. Hoeldtke R.D., O'Dorisio T.M., Boden G. Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995. Lancet 2: 602, 1986.
14. Eriksson L.S., Wahren J. Intravenous and subcutaneous administration of a long-acting somatostatin analogue: effects on glucose metabolism and splanchnic haemodynamics in healthy subjects. Eur. J. Clin. Invest. 19: 213, 1989.
15. Stevenson R.W., Steiner K.E., Hendrick G.K., Cherrington A.D. Effect of somatostatin on glucose homeostasis in conscious long-fasted dogs. Am. J. Physiol. 253: 435, 1987.
16. Donckier J., Hanet C., Berbinschi A., Galanti L., Robert A., Van Mechelen H., Pouleur H., Ketelslegers J.M. Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs. Circulation. 84: 2476, 1991.
17. Sansdrap J., Van Mechelen H., Pouleur H., Charlier A.A CROPA: a research-oriented program for automatic processing of cardiovascular signals. In: Cox J.R., Hugenholtz P.G. (Eds.), Computers in Cardiology. IEEE Computer Society, Firenze 1981, p. 433.
18. Donckier J., De Coster P., Buysschaert M., Levecque P., Cauwe F.M., Brichant C.M., Berbinschi A.C., Ketelslegers J.M. Effect of exercise on plasma atrial natriuretic factor and cardiac function in men and women. Eur. J. Clin. Invest. 18: 415, 1988.
19. Berbinschi A., Ketelslegers J.M. Endothelin in urine. Lancet 2: 46, 1989, (letter).
20. Koch D.D., Palzin G.L. Effect of sample preparation and liquid chromatography column choice on selectivity and precision of plasma catecholamine determination. J. Chromatogr. 386: 19, 1987.
21. Lerman A., Hildebrand F.L., Margulies B., O'Murchu B., Perella M.A., Heublein D.M., Schwab T.R., Burnett J.C. Endothelin: a new cardiovascular regulatory peptide. Mayo Clin. Proc. 65: 1441, 1990.
22. 2+ environment on atrial natriuretic factor release. Am. J. Physiol. 256: H1588, 1989.
23. Kuroski-de Bold M.L, de Bold A.J. Stretch-secretion coupling in atrial cardiocytes. Dissociation between atrial natriuretic factor release and mechanical activity. Hypertension 18 (Supl. III) 169, 1991.
24. Donckier J., De Coster P., Buysschaert M., Van Hoof M., Cauwe F., Robert A., Berbinschi A., Ketelslegers J.M. Effect of ß-adrenergic blockade on plasma atrial natriuretic factor and cardiac volumes during exercise in normal men. Am. J. Cardiol. 63:1000, 1989.
25. Wong N.L.M., Wong E.F., Au G.H., Hu D.C. Effect of α- and ß-adrenergic stimulation on atrial natriuretic peptide release in vitro. Am. J. Physiol. 255: E260, 1988.
26. Sonnenberg H., Veress A.T. Cellular mechanism of release of atrial natriuretic factor. Biochem. Biophys. Res. Commun. 124: 443, 1984.
27. Gilbert E.M., Eiswirth C.C., Mealey P.C., Larrabee P., Herrick C.M., Bristow M.R. ß-adrenergic supersensitivity of the transplanted human heart is presynaptic in origin. Circulation 79: 344, 1989.
28. Lurie K.G., Bristow M.R., Reitz B.A. Increased ß-adrenergic receptor density in an experimental model of cardiac transplantation. J. Thorac. Cardiovasc. Surg. 86: 19, 1983.